Klabauter

[Klabauter @XAberer]

@renabaddie_ 2208

[Iris Bincovich @IrisBincovich]

Innocan ($INNO) is advancing its NYSE listing journey — we're updating our SEC registration for a new submission. More to come. 📈 #Innocan #NYSE #Biotech

[Klabauter @XAberer]

@elonmuskTN 24

[Iris Bincovich @IrisBincovich]

“Super busy to complete a US public offering and NASDAQ listing”

[Iris Bincovich @IrisBincovich]

We're proud to announce that Joseph delivered an acclaimed presentation on our LPT methodology for chronic pain management at PAIN Week. This recognition reinforces our commitment to advancing pain treatment solutions as we prepare for our upcoming Nasdaq listing!!!

[Iris Bincovich @IrisBincovich]

Cannabidiol and Liver Enzyme Level Elevations in Healthy Adults: A Randomized Clinical Trial | Pathology and Laboratory Medicine | JAMA Internal Medicine | JAMA Network https://t.co/yJV2EzaqtU

[Iris Bincovich @IrisBincovich]

"The entire Innocan Pharma team and I are thrilled with having taken this significant step in the process of our listing on the Nasdaq, which opens up exciting new opportunities for us on multiple levels." https://t.co/SXwzXNOEG4

[Iris Bincovich @IrisBincovich]

InnoCan Pharma Stock: Nasdaq Listing Filing Signals Major Leap https://t.co/CQYydoSlhe

[Iris Bincovich @IrisBincovich]

Innocan Pharma intends to continue expanding its intellectual property portfolio https://t.co/jbcSvs9Mgb

[Iris Bincovich @IrisBincovich]

A Novel Solution: LPT-CBD for Chronic Pain Relief

https://t.co/yvh1XqIYQF

[Iris Bincovich @IrisBincovich]

"These findings, highlights the long-lasting effects of repeated administration of LPT-CBD to treat chronic pain" https://t.co/eTtvcQQVte

[Iris Bincovich @IrisBincovich]

Guided by the FDA, for our liposomal CBD therapy (LPD) for chronic pain.we are planning our next steps!

[Iris Bincovich @IrisBincovich]

Very excited 🙏…to our meeting today with the FDA for the LPT … stay tuned

[Iris Bincovich @IrisBincovich]

The basis for the steadily increasing sales of our subsidiary BI SKY GLOBAL figures is a large percentage of repeat customers who are obviously very satisfied with our products. We therefore expect a similar picture in business development in the future.💪

[Iris Bincovich @IrisBincovich]

I am very happy to share our consolidated financial results for Q2, 2024 https://t.co/GKEkjH1ge9

[Iris Bincovich @IrisBincovich]

LPT-CBD is a unique technology that has proven itself worthy of the INAD fee waiver granted by CVM. This will streamline our efforts to deliver a unique solution for chronic pain management to the animal market. https://t.co/iM7eY8o2KD

[Iris Bincovich @IrisBincovich]

Preparation with the experts for Innocan Pharma’s meeting with the FDA……🙏🙏🙏

[Juanita Broaddrick @atensnut]

Still one of my favorite Monty Python skits. 😂😂😂😂

[Iris Bincovich @IrisBincovich]

All our efforts are focused on FDA approval process! We will update you soon...